Company Active LTD

Company profile

Destina Genomics Ltd

DESTINA Nucleic Acid Testing

Destina Genomics Ltd is a UK company with status active founded in 2010 based in Scotland.

CRN
SC377695
Founded
2010
Age
16

Overview

Legal name
DESTINA GENOMICS LTD
Region
Scotland
Registered address
C/O JOHNSTON CARMICHAEL
7-11 MELVILLE STREET
EDINBURGH
SCOTLAND
EH3 7PE
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Destina Genomics Ltd
No active corporate controller recorded.

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FILLETEDACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
3

Company events

Reference milestones and recent Companies House filing stream events.

6 events
12 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

28 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

07 Aug
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzMTUwOTgyM2FkaXF6a2N4

Published 07 Aug 2024 14:12

28 Apr
2010

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2011
Funded years
2011, 2012
Age at first award
1 years

Projects

2012 Feasibility Studies

Feasibility of a rapid, sensitive, nucleic acid based test for detection and serotyping of enteric viruses of human health importance

1 Dec 2012 to 30 Nov 2013

Awarded
£74,958
Total cost £99,984

This project will evaluate the feasibility of a rapid, specific and cheap test for human entric viruses. We will apply our novel patented technology that is able to detect and distinguish specific DNA/RNA sequences as the basis for the test. This will enable viral detection and serotyping, and we suggest that our assay would overcome many of the limitatio...

2012 Feasibility Studies Lead participant

Detection of bovine mastitis pathogens using novel nucleic acid testing technology

1 Aug 2012 to 30 Nov 2012

Awarded
£24,750
Total cost £33,000

The objective of this study is the development of a rapid and cheap multiplexed assay to screen milk prior to processing. This will facilitate the identification of contaminated milk, infected herds and individual animals. The project is innovative in that it will apply novel chemical based nucleic acid detection technology to the identification of bacter...

2011 Feasibility Studies

Novel nucleic acid detection for determining norovirus levels in food

1 May 2011 to 31 Jul 2011

Awarded
£15,000
Total cost £20,000

Awaiting Public Summary

2011 Feasibility Studies Lead participant

Novel companion biomarker assay for glioma cancer drug development to overcome current lack of in-vitro test success

1 May 2011 to 31 Jul 2011

Awarded
£9,041
Total cost £17,250

Awaiting Public Summary

Product types

Feasibility Studies